Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class ASSE: 688266

Announcement on Voluntary Disclosure of Clinical Data and Latest Progress of ZG006 and ZG005 Released at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

· Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Clinical Data and Latest Progress of ZG006 and ZG005 Released at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis